Dr. László Tabár[email protected]Clinical NewsOpinion: Stop misleading women on breast screeningThe article published 5 July by JAMA Oncology about the cost-effectiveness of breast screening is another example of the type of "nonscience" from a leading tabloid journal, writes Dr. László Tabár. Women and decision-makers deserve correct and honest information, and it's time to focus on the harm of not being screened, he notes.July 5, 2018Clinical NewsMammography's alleged harms: Separating fact from fictionScreening mammography is a tool that has been proved to reduce breast cancer death rates, but its effectiveness continues to be disputed by researchers, some of whom have resorted to guesswork to buttress their arguments, according to an opinion piece by mammography experts Dr. László Tabár and Dr. Peter B. Dean.December 13, 2012Clinical NewsAnalysis of Swedish county data is off the markIn this week's study in the Journal of the National Cancer Institute, a research team claimed to find that mammography screening had no impact on mortality from breast cancer, based on their interpretation of data from Swedish counties. However, the group made a number of fatal mistakes in their analysis, according to Dr. László Tabár.July 16, 2012Page 1 of 1Top StoriesMRIAre European pilot sites ready for organized prostate cancer screening?European pilot sites have the clinical capacity for risk-stratified prostate cancer screening but lack the infrastructure needed for implementation, a study found.Radiology EducationSocial media holds promise for radiology educationCTCT 5-star quality rating system supports optimizationOrganized Radiology IssuesJaap Stoker: AI can assist reviewers, but novelty remains humanMolecular ImagingAmyloid PET scores vary with reference-region choice, Spanish study finds
